Loading
Latest filing published 16 Oct 2026 for Natco Pharma Limited, €1,338.
No signal scores available.
Rajeev Nannapaneni discloses dealings in Natco Pharma Limited to SEBI (PIT + SAST). The record holds 2 filings, for trades running from 15 October 2026 to 16 October 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 16 October 2026 came the latest disclosure, a transaction for €1,338 in Natco Pharma Limited. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations